An Overview of PET Radiochemistry, Part 2: Radiometals

This continuing educational review provides an overview on radiometals used for PET. General aspects of radiometal-based radiotracers are covered, and the most frequently applied metallic PET radionuclides, 68Ga, 89Zr, and 64Cu, are highlighted with a discussion of their strengths and limitations.

[1]  W. Oyen,et al.  Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients , 2014, BioMed research international.

[2]  I. Mellinghoff,et al.  Imaging Tumor Burden in the Brain with 89Zr-Transferrin , 2013, The Journal of Nuclear Medicine.

[3]  Jason S. Lewis,et al.  Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System , 2011, The Journal of Nuclear Medicine.

[4]  Michael S. Hofman,et al.  Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT system , 2011, Cancer imaging : the official publication of the International Cancer Imaging Society.

[5]  Mark A Mintun,et al.  Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report. , 2003, International journal of radiation oncology, biology, physics.

[6]  K. Johnston,et al.  Preclinical in vivo application of 152Tb-DOTANOC: a radiolanthanide for PET imaging , 2016, EJNMMI Research.

[7]  Theresa M Reineke,et al.  Theranostics: combining imaging and therapy. , 2011, Bioconjugate chemistry.

[8]  A. Jalilian,et al.  The current status and future of theranostic Copper-64 radiopharmaceuticals , 2016 .

[9]  R. Weissleder,et al.  89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging. , 2011, Bioconjugate chemistry.

[10]  P. Schöffski,et al.  Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data , 2001, European Journal of Nuclear Medicine.

[11]  G. V. van Dongen,et al.  Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[12]  Y Yonekura,et al.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  G. Gasser,et al.  A solid phase-assisted approach for the facile synthesis of a highly water-soluble zirconium-89 chelator for radiopharmaceutical development. , 2017, Dalton transactions.

[14]  J. Ballinger Short- and long-term responses to molybdenum-99 shortages in nuclear medicine. , 2010, The British journal of radiology.

[15]  Carolyn J Anderson,et al.  Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. , 2009, Cancer biotherapy & radiopharmaceuticals.

[16]  C. Villano,et al.  64CuCl2: New theranostic agent , 2014 .

[17]  Jason S. Lewis,et al.  Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO) , 2014, Journal of medicinal chemistry.

[18]  M. Schwaiger,et al.  The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity , 2016, EJNMMI Research.

[19]  H. Haisma,et al.  Evaluation of desferal as a bifunctional chelating agent for labeling antibodies with Zr-89. , 1992, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

[20]  F. Alves,et al.  Cyclotron production of Ga-68 for human use from liquid targets: From theory to practice , 2017 .

[21]  A. Sanchez-Crespo,et al.  Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[22]  A. Terzic,et al.  Novel 89Zr cell labeling approach for PET-based cell trafficking studies , 2015, EJNMMI Research.

[23]  D. Abou,et al.  In vivo biodistribution and accumulation of 89Zr in mice. , 2011, Nuclear medicine and biology.

[24]  H. Wester,et al.  Re-thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals. , 2018, Journal of labelled compounds & radiopharmaceuticals.

[25]  C. E. Knapp,et al.  Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling , 2017, RSC advances.

[26]  R. R. Conry Copper: Inorganic & Coordination Chemistry , 2006 .

[27]  H. Coenen,et al.  Radiolabelling with isotopic mixtures of (52g/55)Mn(II) as a straight route to stable manganese complexes for bimodal PET/MR imaging. , 2016, Dalton transactions.

[28]  H. Herzog,et al.  The Beginning and Development of the Theranostic Approach in Nuclear Medicine, as Exemplified by the Radionuclide Pair 86Y and 90Y , 2017, Pharmaceuticals.

[29]  A. Bauman,et al.  Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET , 2015, The Journal of Nuclear Medicine.

[30]  Simon-Peter Williams,et al.  Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for 89Zr4+ and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice , 2016, Theranostics.

[31]  R. Boellaard,et al.  Performance of Immuno–Positron Emission Tomography with Zirconium-89-Labeled Chimeric Monoclonal Antibody U36 in the Detection of Lymph Node Metastases in Head and Neck Cancer Patients , 2006, Clinical Cancer Research.

[32]  A. Majkowska,et al.  Cyclotron production of 43Sc for PET imaging , 2015, EJNMMI Physics.

[33]  H. Anger,et al.  LOCALIZATION OF BRAIN TUMORS WITH THE POSITRON SCINTILLATION CAMERA. , 1963, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Ido D. Weiss,et al.  MicroPET Imaging of Integrin αvβ3 Expressing Tumors Using 89Zr-RGD Peptides , 2010, Molecular Imaging and Biology.

[35]  Daniel L Smith,et al.  The untapped potential of Gallium 68-PET: the next wave of ⁶⁸Ga-agents. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[36]  R. Hicks,et al.  A desferrioxamine B squaramide ester for the incorporation of zirconium-89 into antibodies. , 2016, Chemical communications.

[37]  S. Huclier-Markai,et al.  Cyclotron production of high purity (44m,44)Sc with deuterons from (44)CaCO3 targets. , 2015, Nuclear medicine and biology.

[38]  D. Le Guludec,et al.  Story of Rubidium-82 and Advantages for Myocardial Perfusion PET Imaging , 2015, Front. Med..

[39]  H. Herzog,et al.  Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[40]  F Rösch,et al.  Past, present and future of 68Ge/68Ga generators. , 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[41]  I. Velikyan Prospective of 68Ga-Radiopharmaceutical Development , 2013, Theranostics.

[42]  G. Schmidt,et al.  Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[43]  J. Engle,et al.  89Zr radiochemistry for positron emission tomography. , 2011, Medicinal chemistry (Shariqah (United Arab Emirates)).

[44]  Jason S. Lewis,et al.  p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for (89)Zr ImmunoPET. , 2015, Bioconjugate chemistry.

[45]  Zahi A. Fayad,et al.  PET Imaging of Tumor-Associated Macrophages with 89Zr-Labeled High-Density Lipoprotein Nanoparticles , 2015, The Journal of Nuclear Medicine.

[46]  O. Boerman,et al.  89Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art 89Zr Radiochemistry , 2017, Bioconjugate chemistry.

[47]  D. Häussinger,et al.  An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes. , 2014, Chemical communications.

[48]  F. Rösch,et al.  Post-elution processing of (44)Ti/(44)Sc generator-derived (44)Sc for clinical application. , 2010, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.